John Nicholson, SVP & Chief Operating Officer at NEKTAR THERAPEUTICS (NKTR), sold 11,964 shares at $38.25 ($458K) on 2018-11-16, disclosed to the SEC on 2018-11-19.
Open-market sale of $458k NKTR by SVP & Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.25 | 5,982 | $229K | 50.0% |
| 2 | $38.25 | 5,982 | $229K | 50.0% |
| Total | $38.25 avg | 11,964 | $458K | 100% |
| Filing → |
| NKTR | SELL | 2019-02-21 | $324K | — | Filing → |
| NKTR | SELL | 2019-01-30 | $2.7M | — | Filing → |
| NKTR | SELL | 2018-05-18 | $820K | — | Filing → |